• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

Abbott

Abbott will spend $450M to up FreeStyle Libre production in Ireland

August 12, 2022 By Chris Newmarker

Abbott (NYSE:ABT) will spend €440 million ($450 million) to expand its operations in Ireland, the country’s government announced today. The investment involves the creation of a new 250,000-square-foot manufacturing facility in Kilkenny and a further investment in the company’s Donegal Diabetes Care site. The investment will add 1,000 new jobs between the sites. The new […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, News Well Tagged With: Abbott, Ireland

Abbott is looking to address biases for cardiovascular patients

August 8, 2022 By Sean Whooley

Earlier this year, Abbott’s (NYSE:ABT) vascular business released a supplement on gender and racial biases in cardiovascular care. According to the 2021 ACC/AHA/SCAI guidelines for Coronary Artery Revascularization, women are less likely to receive cardiac catheterization and more likely to have worse outcomes than their male counterparts. They’re also less likely to be recommended for […]

Filed Under: Business/Financial News, Cardiovascular, Clinical Trials, Featured, Vascular Tagged With: Abbott

Abbott, WeightWatchers partner on diabetes care

August 5, 2022 By Sean Whooley

Abbott (NYSE:ABT) announced that it entered into a strategic partnership with WeightWatchers to help people living with diabetes. The companies will work together to integrate WeightWatchers’ diabetes-tailored weight management program with Abbott’s FreeStyle Libre continuous glucose monitoring (CGM) products to help them better understand and manage their diabetes and weight. According to a news release, the […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, News Well, Patient Monitoring Tagged With: Abbott, WeightWatchers

6 drug delivery innovations you need to know

July 28, 2022 By Sean Whooley

From wearable insulin delivery devices to drug-eluting implants and everything in between, drug delivery innovation never stops. Vaccines, life-saving therapeutics, vision-correcting drugs and more are being developed and marketed for delivery with all kinds of technologies. More than a year ago, we compiled a list of eight drug delivery innovations you need to know. With some […]

Filed Under: Business/Financial News, Diabetes, Drug Pumps, Drug-Device Combinations, Featured, Health Technology, Patient Monitoring, Pharmaceutical, Software / IT Tagged With: Abbott, BD, Bigfoot Biomedical, CeQur, Cook Medical, Dexcom, drug delivery, Insulet, jabil, Johnson & Johnson, Johnson & Johnson Vision, Medtronic, NovaXS, PharmaJet, Phillips-Medisize, Senseonics, Vivera

Abbott launches digital health app for neurostimulation in Canada

July 26, 2022 By Sean Whooley

Abbott (NYSE:ABT) announced today that it received Health Canada licensing for its NeuroSphere Virtual Clinic, enabling it to launch the app. The Abbott Park, Illinois–based company designed the remote programming technology — the first of its kind in Canada — with compatibility with Abbott’s suite of neuromodulation technologies, offering the potential to increase access to […]

Filed Under: Business/Financial News, Digital Health, Featured, Health Technology, Neurological, Neuromodulation/Neurostimulation, News Well, Pain Management, Patient Monitoring, Regulatory/Compliance, Software / IT Tagged With: Abbott, Health Canada

Abbott posts Street-beating Q2, raises 2022 guidance

July 20, 2022 By Sean Whooley

Abbott (NYSE:ABT) shares are down today despite second-quarter results that topped the consensus forecast. The Abbott Park, Illiniois–based company posted profits of more than $2 billion, or $1.14 per share, on sales of $11.3 billion for the three months ended June 30, 2022, for a 69.7% bottom-line gain on sales growth of 10.1%. Adjusted to […]

Filed Under: Business/Financial News, Diagnostics, Featured, Genomics/Molecular Diagnostics, MassDevice Earnings Roundup, Wall Street Beat Tagged With: Abbott

Abbott wins breakthrough nod for deep brain stimulation for managing severe depression

July 12, 2022 By Sean Whooley

Abbott (NYSE:ABT) announced today that it received FDA breakthrough device designation for its deep brain stimulation (DBS) system. The breakthrough nod allows Abbott to investigate the use of its DBS system in treatment-resistant depression (TRD), a form of major depressive disorder (MDD). Abbott Park, Illinois-based Abbott designed its DBS system as a personalized, adjustable therapy […]

Filed Under: Featured, Food & Drug Administration (FDA), Implants, Neurological, Neuromodulation/Neurostimulation, Regulatory/Compliance Tagged With: Abbott, FDA

Abbott Fund grants $750k to education, health equity program

June 23, 2022 By Sean Whooley

Easterseals announced that it received a $750,000 grant from the Abbott Fund to pilot the Project on Education and Community Health Equity. The grant will fund the project from now through 2025, with the three-year initiative aimed at addressing systemic barriers to high-quality education and healthcare experienced by children and families in underserved communities. According […]

Filed Under: Business/Financial News, Funding Roundup, Pediatrics Tagged With: Abbott, Easterseals

Another Medtronic HVAD recall is serious

June 23, 2022 By Chris Newmarker

A year after Medtronic ceded the LVAD market to Abbott, it has yet another Class I recall involving HeartWare Ventricular Assist Device pumps still implanted in patients. The FDA today designated a Medtronic recall involving the HVADs as Class I, the most serious level. It’s the second Class I recall designation for the HVADs this […]

Filed Under: Cardiac Implants, Cardiovascular, Featured, News Well, Recalls, Regulatory/Compliance, Structural Heart Tagged With: Abbott, LVAD, Medtronic

Abbott presents positive data on MitraClip, TriClip heart implants

June 8, 2022 By Sean Whooley

Abbott (NYSE:ABT) today announced late-breaking data supporting its MitraClip and TriClip structural heart solutions. Data for the MitraClip transcatheter edge-to-edge repair (TEER) device and the TriClip minimally invasive tricuspid heart valve repair device were presented at TVT: The Structural Heart Summit, the annual meeting from the Cardiovascular Research Foundation in Chicago. The company said in […]

Filed Under: Cardiac Implants, Cardiovascular, Clinical Trials, Featured, Implants, Replacement Heart Valves, Structural Heart Tagged With: Abbott

The biggest stories from the American Diabetes Association (ADA) 2022 Scientific Sessions

June 8, 2022 By Sean Whooley

For the 82nd time, the American Diabetes Association (ADA) Scientific Sessions convened to highlight all the innovations within the diabetes technology space. Major players like Dexcom, Medtronic, Abbott and more continue to plug along, while companies like Bigfoot Biomedical, One Drop and others shared data backing the technology that they bring to the table. The […]

Filed Under: Business/Financial News, Clinical Trials, Diabetes, Drug Pumps, Drug-Device Combinations, Featured, Health Technology, News Well, Patient Monitoring, Software / IT Tagged With: Abbott, Bigfoot Biomedical, DarioHealth Corp, Dexcom, Insulet, Medtronic, One Drop, Tandem Diabetes Care, Virta Health

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Interim pages omitted …
  • Go to page 96
  • Go to Next Page »

Primary Sidebar

DeviceTalks Weekly

August 12, 2022
DTW – Medtronic’s Mauri brings years of patient care to top clinical, regulatory, scientific post
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy